145 related articles for article (PubMed ID: 27922818)
21. [CD160 characterization and its association with disease progression in patients with chronic HIV-1 infection].
Wang L; Xu X; Feng G; Zhang X; Wang F
Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1559-62. PubMed ID: 25146744
[TBL] [Abstract][Full Text] [Related]
22. Human and mouse mast cells express and secrete the GPI-anchored isoform of CD160.
Ortonne N; Ram-Wolff C; Giustiniani J; Marie-Cardine A; Bagot M; Mecheri S; Bensussan A
J Invest Dermatol; 2011 Apr; 131(4):916-24. PubMed ID: 21191401
[TBL] [Abstract][Full Text] [Related]
23. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.
Cai G; Anumanthan A; Brown JA; Greenfield EA; Zhu B; Freeman GJ
Nat Immunol; 2008 Feb; 9(2):176-85. PubMed ID: 18193050
[TBL] [Abstract][Full Text] [Related]
24. Expansion of CD4 phenotype among CD160 receptor-expressing lymphocytes in murine pregnancy.
Meggyes M; Szereday L; Jakso P; Bogar B; Bogdan A; Nörenberg J; Miko E; Barakonyi A
Am J Reprod Immunol; 2017 Dec; 78(6):. PubMed ID: 28921767
[TBL] [Abstract][Full Text] [Related]
25. Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.
Turner SJ; La Gruta NL; Stambas J; Diaz G; Doherty PC
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3545-50. PubMed ID: 14993609
[TBL] [Abstract][Full Text] [Related]
26. High Levels of CD244 Rather Than CD160 Associate With CD8
Wang X; Wang D; Du J; Wei Y; Song R; Wang B; Qiu S; Li B; Zhang L; Zeng Y; Zhao H; Kong Y
Front Immunol; 2022; 13():853522. PubMed ID: 35386693
[TBL] [Abstract][Full Text] [Related]
27. CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+ T Cells.
Zhang L; Zhang A; Xu J; Qiu C; Zhu L; Qiu C; Fu W; Wang Y; Ye L; Fu YX; Zhao C; Zhang X; Xu J
Front Immunol; 2020; 11():2188. PubMed ID: 33072082
[TBL] [Abstract][Full Text] [Related]
28. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivity.
Nakagomi D; Suzuki K; Hosokawa J; Kobayashi Y; Suto A; Takatori H; Watanabe N; Matsue H; Murphy TL; Murphy KM; Shimada S; Nakajima H
J Invest Dermatol; 2013 Mar; 133(3):702-711. PubMed ID: 23190882
[TBL] [Abstract][Full Text] [Related]
30. Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.
Baranowska M; Hauge AG; Hoornaert C; Bogen B; Grødeland G
Vaccine; 2015 Dec; 33(49):6988-96. PubMed ID: 26387432
[TBL] [Abstract][Full Text] [Related]
31. Expanded antigen-experienced CD160
Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
[TBL] [Abstract][Full Text] [Related]
32. Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression.
Marshall DR; Olivas E; Andreansky S; La Gruta NL; Neale GA; Gutierrez A; Wichlan DG; Wingo S; Cheng C; Doherty PC; Turner SJ
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6074-9. PubMed ID: 15831586
[TBL] [Abstract][Full Text] [Related]
33. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
34. Sirolimus-based regimen promotes inhibitory costimulatory signal of HVEM/BTLA/CD160/LIGHT pathway in allo-renal recipients.
Bai Y; Shi Y; Li Y; Cai B; Zou Y; Wang L
Transpl Immunol; 2013 Jan; 28(1):38-47. PubMed ID: 23165214
[TBL] [Abstract][Full Text] [Related]
35. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses.
Fernando GJ; Zhang J; Ng HI; Haigh OL; Yukiko SR; Kendall MA
J Control Release; 2016 Sep; 237():35-41. PubMed ID: 27381247
[TBL] [Abstract][Full Text] [Related]
36. B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation.
Krieg C; Boyman O; Fu YX; Kaye J
Nat Immunol; 2007 Feb; 8(2):162-71. PubMed ID: 17206146
[TBL] [Abstract][Full Text] [Related]
37. BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine.
Kannan S; Kurupati RK; Doyle SA; Freeman GJ; Schmader KE; Ertl HC
Oncotarget; 2015 Aug; 6(23):19445-55. PubMed ID: 26277622
[TBL] [Abstract][Full Text] [Related]
38. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
Liu W; Chou TF; Garrett-Thomson SC; Seo GY; Fedorov E; Ramagopal UA; Bonanno JB; Wang Q; Kim K; Garforth SJ; Kakugawa K; Cheroutre H; Kronenberg M; Almo SC
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34709351
[TBL] [Abstract][Full Text] [Related]
39. CD160 is essential for NK-mediated IFN-γ production.
Tu TC; Brown NK; Kim TJ; Wroblewska J; Yang X; Guo X; Lee SH; Kumar V; Lee KM; Fu YX
J Exp Med; 2015 Mar; 212(3):415-29. PubMed ID: 25711213
[TBL] [Abstract][Full Text] [Related]
40. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
